Anthim: Completed pivotal trial enrollment

Elusys completed enrollment of 70 adult volunteers in a double-blind, placebo-controlled, U.S. pivotal trial evaluating 16 mg/kg IV ETI-204 given on days 1 and 14 or days 1 and 120. The compound has O...